1. MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma
   Julius Moratin et al, 2019, Journal of Cranio-Maxillofacial Surgery CrossRef
2. Appropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma
   Eleonore Longton et al, 2018, Frontiers in Oncology CrossRef
3. Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma
   Xinfang Mao et al, 2017, Oncotarget CrossRef
4. Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines
   Roman Brands et al, 2018, Oncology Letters CrossRef
5. ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy
   Ozlen Saglam et al, 2017, Cancer Control CrossRef
6. Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines
   Ines De Pauw et al, 2018, Molecular Oncology CrossRef
7. Psorachromene Suppresses Oral Squamous Cell Carcinoma Progression by Inhibiting Long Non-coding RNA GAS5 Mediated Epithelial-Mesenchymal Transition
   Tong-Hong Wang et al, 2019, Frontiers in Oncology CrossRef
8. Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy
   Laveniya Satgunaseelan et al, 2021, Frontiers in Oncology CrossRef
9. Axl contributes to efficient migration and invasion of melanoma cells
   Hanshuang Shao et al, 2023, PLOS ONE CrossRef
10. The efficacy and safety of EGFR‐TKI in recurrent/metastatic nasopharyngeal carcinoma patients: A systematic review and meta‐analysis
    Zeqi An et al, 2024, Laryngoscope Investigative Otolaryngology CrossRef
11. Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
    Adelina Plangger et al, 2022, Investigational New Drugs CrossRef
12. Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro
    Roman C. Brands et al, 2020, Journal of Cranio-Maxillofacial Surgery CrossRef